Novo Nordisk's market cap is currently $369.52B. The company's EPS TTM is €2.848; its P/E ratio is 29.28; and it has a dividend yield of 1.24%. Novo Nordisk is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is €0.80. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	kr 232.26B	kr 176.95B	kr 140.80B	kr 126.95B	kr 122.02B
Gross Profit	kr 196.50B	kr 148.51B	kr 117.14B	kr 106.01B	kr 101.93B
Operating Income	kr 102.57B	kr 74.81B	kr 58.64B	kr 54.13B	kr 52.48B
EBITDA	kr 113.33B	kr 82.04B	kr 65.39B	kr 59.27B	kr 57.79B
Net Income	kr 83.68B	kr 55.52B	kr 47.76B	kr 42.14B	kr 38.95B
Balance Sheet
Cash & Short-Term Investments	kr 30.23B	kr 23.57B	kr 17.48B	kr 12.76B	kr 15.47B
Total Assets	kr 314.49B	kr 241.26B	kr 194.51B	kr 144.92B	kr 125.61B
Total Debt	kr 27.01B	kr 25.78B	kr 26.64B	kr 10.36B	kr 4.48B
Net Debt	kr 12.61B	kr 13.13B	kr 15.93B	kr -2.40B	kr -10.99B
Total Liabilities	kr 207.93B	kr 157.77B	kr 123.76B	kr 81.60B	kr 68.02B
Stockholders' Equity	kr 106.56B	kr 83.49B	kr 70.75B	kr 63.33B	kr 57.59B
Cash Flow
Free Cash Flow	kr 70.01B	kr 64.13B	kr 47.62B	kr 29.87B	kr 35.55B
Operating Cash Flow	kr 108.91B	kr 78.89B	kr 55.00B	kr 51.95B	kr 46.78B
Investing Cash Flow	kr -43.89B	kr -24.92B	kr -31.61B	kr -22.44B	kr -11.51B
Financing Cash Flow	kr -63.16B	kr -51.80B	kr -25.49B	kr -32.24B	kr -35.48B

Currency in DKK

Novo Nordisk Earnings and Revenue History

Income Statement >

Novo Nordisk Debt to Assets

Balance Sheet >

Novo Nordisk Cash Flow

Cash Flow >

Novo Nordisk Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing